We are live on
!
Find out more
AA
Aufman Associates Portfolio holdings
AUM
$204M
1-Year Est. Return
39.64%
This Fund
S&P 500
This Quarter
Est. Return
-4.91%
1 Year Est. Return
+39.64%
3 Year Est. Return
+76.39%
5 Year Est. Return
+74.89%
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$8.3M
(-6.1%)
Cap. Flow
-$600K
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
86.46%
Holding
55
New
1
Increased
19
Reduced
17
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.18M |
| 2 |
AMC Global Media
AMCX
|
+$805K |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$369K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$233K |
| 5 |
iShares ESG Advanced MSCI USA ETF
USXF
|
+$98.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$2.21M |
| 2 |
Verizon
VZ
|
+$294K |
| 3 |
Lowe's Companies
LOW
|
+$220K |
| 4 |
PNC Financial Services
PNC
|
+$216K |
| 5 |
PepsiCo
PEP
|
+$211K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.35% |
| 2 | Real Estate | 3.14% |
| 3 | Financials | 2.3% |
| 4 | Communication Services | 2.22% |
| 5 | Healthcare | 1.98% |
Similar funds
II
CAM
KFA
OF
TBBL
WA1
TCM
RA
Aufman Associates's Q1 2022 Portfolio in Review
As of Q1 2022, Aufman Associates held 55 positions worth $127M, down 6.1% from $135M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Aufman Associates's Q1 2022 filing shows 1 new, 19 increased, 17 reduced and 8 closed positions. Its largest new stake was AMC Global Media: 19,923 shares worth $809K. The largest sale was Apellis Pharmaceuticals, an estimated $2.21M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Real Estate and Financials.
- Aufman Associates's largest Q1 2022 buy was AMC Global Media: 19,923 shares worth $809K.
- Aufman Associates added most to Vanguard S&P 500 ETF in Q1 2022, an estimated $2.18M increase.
- Aufman Associates's biggest Q1 2022 reduction was ExxonMobil, cutting an estimated $196K.
- Aufman Associates fully exited Apellis Pharmaceuticals in Q1 2022, selling an estimated $2.21M.
- Aufman Associates's ten largest holdings make up 86% of its $127M portfolio in Q1 2022.
- Aufman Associates opened 1 new position and closed 8 in Q1 2022.
- Aufman Associates's portfolio value fell 6.1% quarter-over-quarter to $127M.
Based on Aufman Associates's 13F filing for Q1 2022, filed 13 May 2022.